我們已在上線!
進一步了解
LHDX
Lucira Health, Inc. Common Stock
LHDX
LHDX
已下市
LHDX已於2023年3月3日下市。
關於: Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.
員工: 221
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於LHDX的最新新聞文章。
價格圖表採用Lightweight Charts™實作